Lonza in Netherlands
E-mail: -
Web: https://pharma.lonza.com/
Address:
-
Office Lonza in Netherlands
Urmonderbaan 20B, Geleen 6167 RD
Phone: +31 43 35 09910
Fax: -
Other Lonza's locations around the world
Clinical Trials sponsored by Lonza
-
Lonza Ltd.CompletedHealthy Volunteers | Recovery | Endothelial FunctionGermany
-
Biofortis, Merieux NutriSciencesLonza Inc.CompletedGut MicrobiotaUnited States
-
KGK Science Inc.Lonza Inc.Completed
-
Biofortis, Merieux NutriSciencesLonza Inc.Completed
-
Applied Science & Performance InstituteLonza Ltd.CompletedOxidative Stress | Muscle Soreness | Muscle Strength | Muscle Damage | Resistance TrainingUnited States
-
Applied Science & Performance InstituteLonza Ltd.CompletedBody Composition | Oxidative Stress | Muscle Strength | Muscle Damage | Resistance TrainingUnited States
-
Applied Science & Performance InstituteLonza Ltd.CompletedOxidative Stress | Muscle Strength | Muscle Damage | Resistance Training | Immune SuppressionUnited States
-
Applied Science & Performance InstituteLonza Ltd.CompletedBody Composition | Oxidative Stress | Muscle Strength | Muscle Damage | Resistance TrainingUnited States
-
Fred Hutchinson Cancer CenterLonza Walkersville, Inc.RecruitingStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Ductal AdenocarcinomaUnited States
About Lonza
Innovation lies at the heart of our mission to enable our customers to meet challenging deadlines and address their patients’ needs. Research & Development (R&D) plays a central role in how we approach innovation. It provides us with a long-term vision and ensures we make appropriate investments into extending our technology and capabilities to develop the tools we need for our future success.
Our scientific mindset, 360º view of industry trends and experience in transforming discovery into manufacturing applications, have been applied on multiple fronts throughout 2020. Our 14 R&D sites worldwide are an integral part of our global network and support innovation across the business.
Innovation does not happen in isolation. It is underpinned by strong synergies across all our R&D focus areas. Our R&D group is active in viral vectors, cell line construction, cell culture media, cell and gene therapies, capsule design and manufacturing, other oral dosage forms, chemical active pharmaceutical ingredients (APIs) and parenteral formulation and delivery. It is also involved in bio manufacturing and digital technology. Our key areas of interest are summarized here.